WUXAY News and Press, Wuxi AppTec Co. Ltd. ADR From 04/24/22

Wuhan Binhui Biopharm closed a $47 million Series B financing to support its R&D of oncolytic virus products. Amoy Diagnostics, a Shanghai novel molecular diagnostics company, signed a collaboration agreement to develop companion diagnostics for AstraZeneca drugs. Hangzhou Asc...

WuXi AppTec press release (OTCPK:WUXAY): FY Non-GAAP EPS of RMB1.75. Revenue of RMB22.9B (+38.5% Y/Y). For further details see: WuXi AppTec Non-GAAP EPS of RMB1.75, revenue of RMB22.9B

WuXi AppTec Reports Strong Revenue Growth in 2021 PR Newswire Revenue Up 38.5% Year-Over-Year to RMB22,902 Million Net Profit Attributable to Owners of the Company Up 72.2% Year-Over-Year to RMB5,097 Million Diluted Earnings Per Share (EPS) Up 6...

WuXi ATU Announces Launch of TESSA™ Technology to Improve Scalability and Accessibility of Cell and Gene Therapies TESSA™ technology provides a scalable process for manufacturing gene therapies, accelerating the production of large quantities of therapeutic DNA req...

Statement by WuXi AppTec Regarding Recent Market Fluctuation PR Newswire SHANGHAI , Dec. 15, 2021 /PRNewswire/ -- Our company's activities continue apace and we remain confident in our platform, which enables our global customers and serves patients around the wo...

WuXi AppTec Receives 2021 Global Customer Value Leadership Award from Frost & Sullivan WuXi AppTec Receives 2021 Global Customer Value Leadership Award from Frost & Sullivan PR Newswire SHANGHAI , Dec. 8, 2021 /PRNewswire/ -- WuXi AppTec, a l...

WuXi AppTec (OTCPK:WUXAY): Q3 Non-GAAP EPS of RMB0.46; GAAP EPS of RMB0.30. Revenue of RMB5.98B (+30.6% Y/Y) Press Release For further details see: WuXi AppTec reports Q3 results

WuXi AppTec Reports Strong Third-Quarter 2021 Results PR Newswire Revenue Up 30.6% Year-Over-Year to RMB5,985 Million Net Profit Attributable to Owners of the Company Up 36.2% Year-Over-Year to RMB887 Million Diluted EPS Up 30.4% Year-Over-Year&...

WuXi AppTec Receives AA ESG Rating from MSCI WuXi AppTec upgraded to an AA environmental, social and governance (ESG) rating by Morgan Stanley Capital International PR Newswire SHANGHAI , Sept. 5, 2021 /PRNewswire/ -- WuXi AppTec ("the Company") is pleas...

WuXi AppTec (WUXAY): Q1 Non-GAAP EPS of RMB0.38; GAAP EPS of RMB0.61.Revenue of RMB4.95B (+55.3% Y/Y)Press Release For further details see: WuXi AppTec reports Q1 results